January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
According to market estimations the in vitro lung model market to rise from $432.76 million in 2025 to $943.61 million by 2030. North America, having dominated the market with a 45.1% share in 2023, will continue to be a key player, while the pharmaceutical and biotechnology companies segment remains dominant in terms of end-use....
April 21, 2026
According to market projections, the global multiplex detection immunoassay market, valued at USD 2.82 billion in 2024, is anticipated to reach USD 7.81 billion by 2034, growing at a CAGR of 9.75% over the next decade. The increasing research in genomics, proteomics, biopharmaceuticals, and clinical diagnostics drives the market....
April 21, 2026
According to market projections, the global AI in diagnostics market, valued at USD 1.74 billion in 2025, is anticipated to reach USD 12.65 billion by 2035, growing at a CAGR of 24.64% over the next decade. The demand for AI in diagnostic testing has increased significantly due to the various benefits AI provides. One of the major benefits is reduc...
April 21, 2026
The immunodiagnostics market is growing with innovations like ELISA, CLIA, and fluorescent immunoassays. The National Institute of Biologicals and regulatory bodies oversee quality and safety for diagnostics, while companies like Thermo Fisher and Serum Institute advance solutions for disease detection and research....
April 21, 2026
The C-reactive protein (CRP) test measures inflammation levels in the body, aiding in diagnosing conditions like infections, autoimmune disorders, and heart disease risk. Demand is growing due to aging populations and advanced technologies. Innovations include rapid, sensitive point-of-care CRP tests....
April 21, 2026
Cardiac biomarkers like troponin, CK, and myoglobin help diagnose heart attacks by detecting damage to the heart. As heart disease rises globally, the demand for these tests increases, aiding early diagnosis and reducing healthcare costs. Recent innovations include Mindray's advanced troponin test and funding for heart disease detection tech....
April 21, 2026
The exosome diagnostic and therapeutic market focuses on innovative research for diagnosing health disorders and monitoring treatments. Exosomes, found in body fluids, are used in cancer therapy, immune modulation, and drug delivery. Companies like Capricor Therapeutics advance exosome-based treatments....
April 21, 2026
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global Strategy and investments, such as DNA Wellness' 100 labs, are boosting awareness and detection effor...
April 21, 2026
The medical imaging reagents market includes various agents used in diagnostic techniques like MRI, X-ray, and PET. These reagents help in detecting diseases, monitoring cellular functions, and improving early diagnosis. Companies like Siemens Healthineers and GE Healthcare are advancing imaging technologies, with AI enhancing accuracy and efficien...
April 21, 2026
Organ-on-a-chip (OoC) systems use tiny tissues in microfluidic chips to mimic human physiology. By improving drug development, accuracy, and cost efficiency, OoCs offer a more precise alternative to animal models. The FDA’s 2022 act supports using non-animal data for clinical trials, advancing research....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
